Bloomberg Law
Health Law & Business
LinkedIn

Mylan Recalls Lot of Octreotide Acetate Injection, 500 mcg/mL

Oct. 26, 2022, 12:49 PM UTC
Allegra Fradkin
Allegra Fradkin

Mylan Institutional is recalling one lot of Octreotide Acetate Injection, 500 mcg/mL, packaged in a carton of ten 1mL syringes, according to an FDA statement.

  • Due to product complaint of the presence of glass particles in a syringe
  • Lot manufactured by Italfarmaco SpA, Italy and distributed by Mylan in the US between January 11 and June 21, 2022

To contact the reporter on this story:
Allegra Fradkin in New York at afradkin@bloomberg.net

To contact the editor responsible for this story:
Chakradhar Adusumilli at cadusumilli@bloomberg.net

© 2022 Bloomberg L.P. All rights reserved. Used with permission.

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.